Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

17-1884 - Klein et al v. Prime Therapeutics, LLC et al


Download Files

Metadata

Document in Context
17-1884 - Klein et al v. Prime Therapeutics, LLC et al
February 1, 2018
PDF | More
ORDER: Pursuant to the parties' Stipulations (188 in 17-cv-1884), (143 in 18-cv-18, and (46 in 17-cv-5154), IT IS HEREBY ORDERED that these matters are consolidated for all purposes and captioned as "In re EpiPen ERISA Litigation", Civil No. 17-1884 (PAM/SER), and further ordering. (Written Opinion). Signed by The Hon. Paul A. Magnuson on 02/01/2018. (LLM) Associated Cases: 0:17-cv-01884-PAM-SER, 0:17-cv-05154-PAM-SER, 0:18-cv-00018-PAM-SER
April 2, 2018
PDF | More
ORDER granting 154 Motion for Further Consideration of Sealing; granting 160 Motion for Further Consideration of Sealing; granting 166 Motion for Further Consideration of Sealing. Permanent Sealing GRANTED for Document Number(s): 53, 58, 59, 60, 61, 63, 67, 70, 71, 74, 75, 76, 81, 84. Order on continued sealing becomes final on 4/23/2018 unless further timely submissions are filed.(Written Opinion) Signed by Magistrate Judge Steven E. Rau on 4/2/2018. (BDB)